Pharmacoeconomics of selective decontamination of the digestive tract in intensive care patients: a US perspective.
Department of Pharmacotherapy and Research, Tampa General Hospital, Departments of Anesthesiology and Surgery, University of South Florida.
S J
SJ
Markowsky
J
J
Christie
D000900:Anti-Bacterial Agents; D001424:Bacterial Infections / Q000401:mortality / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D003422:Critical Care / Q000379:methods*; D003428:Cross Infection / Q000517:prevention & control*; D004064:Digestive System / Q000382:microbiology*; D016527:Drug Costs; D004359:Drug Therapy, Combination / Q000191:economics / Q000494:pharmacology*; D004363:Drug Utilization; D017850:Economics, Pharmaceutical; D006801:Humans; D012307:Risk Factors; D014481:United States